https://medicaldialogues.in/news/industry/pharma/novartis-teijin-pharma-ink-pact-for-preclinical-candidate-for-proteinuric-kidney-diseases-108161
Novartis, Teijin Pharma ink pact for preclinical candidate for proteinuric kidney diseases